SEC Form 4 · accession 0001209191-15-024970

Xylem Inc. · XYL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP & Chief HR Officer

Period of report

Mar 9, 2015

Accepted (ET)

Mar 11, 2015 · 10:24 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001524472

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 9, 2015	M	5,063	$24.60	A	21,996	D
Common Stock^F1	Mar 9, 2015	S	5,063	$35.3426	D	16,933	D
Common Stock	Mar 9, 2015	M	8,648	$26.60	A	25,581	D
Common Stock^F1	Mar 9, 2015	S	8,648	$35.3426	D	16,933	D
Common Stock	Mar 9, 2015	M	13,394	$27.49	A	30,327	D
Common Stock^F1	Mar 9, 2015	S	13,394	$35.3426	D	16,933	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$24.60	Mar 9, 2015	M	5,063	D	—	Nov 7, 2021	common stock	5,063	0	D
Stock Option (Right to Buy)^F2	$26.60	Mar 9, 2015	M	8,648	D	—	Mar 2, 2022	common stock	8,648	0	D
Stock Option (Right to Buy)^F3	$27.49	Mar 9, 2015	M	13,394	D	—	Mar 2, 2023	common stock	13,394	6,697	D

F1This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $35.26 to $35.47 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2These options are fully vested and exercisable.
F3The original grant of 20,091 options vests in three equal installments. The remaining 6,697 will vest on March 1, 2016.